This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Wu, Y. Articles by Ip, C. Search for Related Content PubMed PubMed Citation Articles by Wu, Y. Articles by Ip, C.

Endoplasmic Reticulum Stress Signal Mediators Are Targets of Selenium Action

Departments of ¹ Cancer Chemoprevention and ² Cellular Stress Biology, Roswell Park Cancer Institute, Buffalo, New York

Requests for reprints: Clement Ip, Department of Cancer Chemoprevention, Roswell Park Cancer Institute, Elm and Carlton Streets, Buffalo, NY 14263. Phone: 716-845-8875; Fax: 716-845-8100; E-mail: clement.ip{at}roswellpark.org.

A monomethylated selenium metabolite, called methylseleninic acid (MSA), has recently been shown to cause global thiol redox modification of proteins. These changes represent a form of cellular stress due to protein misfolding or unfolding. An accumulation of aberrantly folded proteins in the endoplasmic reticulum (ER) triggers a defined set of transducers to correct the defects or commit the cells to apoptosis if the rescue effort is exhausted. Treatment of PC-3 human prostate cancer cells with MSA was found to induce a number of signature ER stress markers: (a) the survival/rescue molecules such as phosphorylated protein kinase–like ER-resident kinase (phospho-PERK), phosphorylated eukaryotic initiation factor-2 (phospho-eIF2), glucose-regulated protein (GRP)-78, and GRP94; and (b) the apoptotic molecules such as caspase-12, caspase-7, and CAAT/enhancer binding protein homologous protein or growth arrest DNA damage-inducible gene 153 (CHOP/GADD153). Additional evidence suggested that CHOP/GADD153 might be an important transcription factor in apoptosis induction by MSA. In general, a higher concentration of MSA was required to elicit the apoptotic markers compared with the rescue markers. The apoptotic markers increased proportionally with the dose of MSA, whereas the rescue markers failed to keep pace with the increasing challenge from MSA. GRP78 is the rheostat of the ER stress transducers. In GRP78-overexpressing cells, the ability of MSA to up-regulate phospho-PERK, phospho-eIF2, GRP94, caspase-12, caspase-7, and CHOP/GADD153 was significantly muted. A generous supply of GRP78 would allow cells to cope better with ER stress, thereby improving the odds for survival and negating the commitment to apoptotic death. The present study thus provides strong evidence to support an important role of ER stress response in mediating the anticancer effect of selenium.

This article has been cited by other articles:

				C.-C. Chiu, C.-Y. Lin, L.-Y. Lee, Y.-J. Chen, T.-F. Kuo, J. T.-C. Chang, C.-T. Liao, H.-M. Wang, T.-C. Yen, C.-R. Shen, et al. Glucose-regulated protein 78 regulates multiple malignant phenotypes in head and neck cancer and may serve as a molecular target of therapeutic intervention Mol. Cancer Ther., September 1, 2008; 7(9): 2788 - 2797. [Abstract] [Full Text] [PDF]

				L. Ou, Y. Wu, C. Ip, X. Meng, Y.-C. Hsu, and M. M. Ip Apoptosis induced by t10,c12-conjugated linoleic acid is mediated by an atypical endoplasmic reticulum stress response J. Lipid Res., May 1, 2008; 49(5): 985 - 994. [Abstract] [Full Text] [PDF]

				A. Kardosh, E. B. Golden, P. Pyrko, J. Uddin, F. M. Hofman, T. C. Chen, S. G. Louie, N. A. Petasis, and A. H. Schonthal Aggravated Endoplasmic Reticulum Stress as a Basis for Enhanced Glioblastoma Cell Killing by Bortezomib in Combination with Celecoxib or Its Non-Coxib Analogue, 2,5-Dimethyl-Celecoxib Cancer Res., February 1, 2008; 68(3): 843 - 851. [Abstract] [Full Text] [PDF]

				S. Liu, H. Zhang, L. Zhu, L. Zhao, and Y. Dong Kruppel-Like Factor 4 Is a Novel Mediator of Selenium in Growth Inhibition Mol. Cancer Res., February 1, 2008; 6(2): 306 - 313. [Abstract] [Full Text] [PDF]

				S. Juliger, H. Goenaga-Infante, T. A. Lister, J. Fitzgibbon, and S. P. Joel Chemosensitization of B-Cell Lymphomas by Methylseleninic Acid Involves Nuclear Factor-{kappa}B Inhibition and the Rapid Generation of Other Selenium Species Cancer Res., November 15, 2007; 67(22): 10984 - 10992. [Abstract] [Full Text] [PDF]

				S. Li, Y. Zhou, R. Wang, H. Zhang, Y. Dong, and C. Ip Selenium sensitizes MCF-7 breast cancer cells to doxorubicin-induced apoptosis through modulation of phospho-Akt and its downstream substrates Mol. Cancer Ther., March 1, 2007; 6(3): 1031 - 1038. [Abstract] [Full Text] [PDF]

				J. M. Cerutti, F. R.M. Latini, C. Nakabashi, R. Delcelo, V. P. Andrade, M. J. Amadei, R. M.B. Maciel, F. C. Hojaij, D. Hollis, J. Shoemaker, et al. Diagnosis of Suspicious Thyroid Nodules Using Four Protein Biomarkers. Clin. Cancer Res., June 1, 2006; 12(11): 3311 - 3318. [Abstract] [Full Text] [PDF]

				Y. Wu, K. Zu, M. A. Warren, P. K. Wallace, and C. Ip Delineating the mechanism by which selenium deactivates Akt in prostate cancer cells. Mol. Cancer Ther., February 1, 2006; 5(2): 246 - 252. [Abstract] [Full Text] [PDF]